EUVIMEDEUVIMED entdecken
Open Access

Identification of programmed cell death-related subtypes reveals immune heterogeneity and therapeutic divergence in colon cancer

Peng Xia, Ying Qu, Quanzhong Liu, Mengyan Zhu, Bin Huang, Wei Wu, Kening Li, Lingxiang Wu, Ruohan Zhang, Yingli Lv, Qianghu Wang

Theranostics · 18.02.2026 · 16 (9) · 4821-4840

DOI: 10.7150/thno.126314 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, erschienen am 18.02.2026. Verfasst von Peng Xia und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Science & Medical Engineering, Southeast University, Nanjing 211189, China. Hauptthemen laut MEDLINE: Colonic Neoplasms, Apoptosis, Adenocarcinoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsApoptosisAdenocarcinomaHumansTumor MicroenvironmentDrug Resistance, NeoplasmMolecular Docking SimulationGene Expression ProfilingAntineoplastic AgentsTranscriptomeDrug RepositioningGene Expression Regulation, NeoplasticImmunotherapy

Stichwörter der Autor:innen

colon adenocarcinomamolecular subtypestherapy resistancetumor microenvironment

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • School of Biological Science & Medical Engineering, Southeast University, Nanjing 211189, China.
  • Department of Bioinformatics, Nanjing Medical University, Nanjing 211166, China.
  • Institute for Brain Tumors, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China.
  • Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
  • College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China.
  • The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Key Laboratory of Innovative Cancer Diagnosis & Therapeutics, Nanjing 210009, China.

Zitieren

APA

Xia, P., Qu, Y., Liu, Q., Zhu, M., Huang, B., Wu, W., Li, K., Wu, L., Zhang, R., Lv, Y., & Wang, Q. (2026). Identification of programmed cell death-related subtypes reveals immune heterogeneity and therapeutic divergence in colon cancer. Theranostics, 16(9), 4821-4840. https://doi.org/10.7150/thno.126314

Vancouver

Xia P, Qu Y, Liu Q, Zhu M, Huang B, Wu W, et al. Identification of programmed cell death-related subtypes reveals immune heterogeneity and therapeutic divergence in colon cancer. Theranostics. 2026;16(9):4821-4840. doi:10.7150/thno.126314

BibTeX
@article{Xia2026,
  author = {Xia, Peng and Qu, Ying and Liu, Quanzhong and Zhu, Mengyan and Huang, Bin and Wu, Wei and Li, Kening and Wu, Lingxiang and Zhang, Ruohan and Lv, Yingli and Wang, Qianghu},
  title = {Identification of programmed cell death-related subtypes reveals immune heterogeneity and therapeutic divergence in colon cancer},
  journal = {Theranostics},
  year = {2026},
  volume = {16},
  number = {9},
  pages = {4821--4840},
  doi = {10.7150/thno.126314}
}
Kostenlos starten →